Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combo Product Sponsors Convince US FDA To Change Postmarket Reporting Rule

Executive Summary

Final reg includes several clarifications about its scope and definitions, and also includes some additional reporting requirements.

Advertisement

Related Content

Combo Product Review Pilot At US FDA Will Offer All Applications Intercenter Consults
Cures Bill Authorizes Inter-Center Institutes, But Will US FDA Create Them?
Combo Product Safety: US FDA Rule On Postmarket Reporting Nears Finalization
21st Century Cures: Device Provisions

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS119703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel